Regulation of neuropeptide Y mRNA expression in cultured human pheochromocytoma cells

European Journal of Endocrinology

Volumn 141, Issue 4, 1999, Pages 431-435

  Liu, Jianqi ^a,b   Kahri, Arvi I ^a   Heikkilä, Päivi ^a   Voutilainen, Raimo ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; PROTEIN KINASE; SOMATOMEDIN B; STAUROSPORINE;

ADRENAL MEDULLA; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CHROMAFFIN CELL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RNA ANALYSIS;

ADRENAL GLAND NEOPLASMS; ADRENAL MEDULLA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROPEPTIDE Y; PHEOCHROMOCYTOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032753772     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410431     Document Type: Article

References (21)

1. White JD, Neuropeptide Y: a central regulator of energy homeostasis. Regulatory Peptides 1993 49 93-107.
2. Allen JM, Biecham PMM, Bloom SR & Edwards AV. Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. Journal of Physiology 1984 357 401-408.
3. 2+ channels and protein kinases. Journal of Neurochemistry 1996 67 1090-1099.
4. Hinson JP, Cameron LA & Kapas S. Neuropeptide Y modulates the sensitivity of the rat adrenal cortex to stimulation by ACTH. Journal of Endocrinology 1995 145 283-289.
5. Pruszczyk P, Wocial B, Ignatowska-Switalska H, Feltynowski T, Ellafi M, Januszewicz A, Lapinski M, Zukowska-Grojec Z & Januszewicz W. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor? Clinica Chimica Acta 1995 243 205-212.
6. deS Senanayake P, Denker J, Bravo EL & Graham RM. Production, characterization, and expression of neuropeptide Y by human pheochromocytoma. Journal of Clinical Investigation 1995 96 2503-2509.
7. Grouzmann E, Comoy E & Bohuon C. Plasma neuropeptide-Y concentrations in patients with neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 1989 68 808-813.
8. Januszewicz W, Wocial B, Ignatowska-Switalska H, Dutkiewicz-Raczkowska M, Feltynowski T, Januszewicz A, Lapinski M, Zukowska-Grojec Z & Szostek M. Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma. Journal of Hypertension 1998 16 543-547.
9. Helman LJ, Cohen PS, Averbuch SD, Cooper MJ, Keiser HR & Israel MA. Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma. Journal of Clinical Oncology 1989 7 1720-1725.
10. Osamura RY, Tsutsumi Y, Yanaihara N, Imura H & Watanabe K. Immunohistochemical studies for multiple peptide-immunoreactivities and co-localization of Met-enkephalin-Arg-Gly-Leu, neuropeptide Y and somatostatin in human adrenal medulla and pheochromocytomas. Peptides 1987 8 77-87.
11. Higuchi H, Iwasa A & Yokokawa K. High levels of expression of neuropeptide Y mRNA in human phaeochromocytomas. Clinical and Experimental Pharmacology and Physiology 1994 21 359-365.
12. Rajakumar PA, Westfall TC & Devaskar SU. Neuropeptide Y gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines. Regulatory Peptides 1998 73 123-131.
13. Tischler AS, Allen JM, Costopoulos D & Bloom SR. Increased content of neuropeptide Y in human pheochromocytoma cell cultures. Journal of Clinical Endocrinology and Metabolism 1985 61 303-305.
14. Liu J, Kahri AI, Heikkilä P, Blum WF & Voutilainen R. Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human phaeochromocytoma cells. Journal of Endocrinology 1994 142 29-35.
15. Minth CD, Bloom SR, Polak JM & Dixon JE. Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proceedings of the National Academy of Sciences of the USA 1984 81 4577-4581.
16. Arnheim N. Characterization of mouse ribosomal gene fragments purified by molecular cloning. Gene 1979 7 83-96.
17. Pfragner R & Walser V. Long-term tissue culture of human pheochromocytomas. Experimentelle Pathologie 1980 18 423-429.
18. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC & Påhlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. American Journal of Pathology 1995 146 833-847.
19. Lerchen RA, Yum DY, Krajcik R & Minth-Worby CA. Transcriptional vs posttranscriptional control of neuropeptide Y gene expression. Endocrinology 1995 136 833-841.
20. Jalava A, Akerman K & Heikkilä J. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Journal of Cellular Physiology 1993 155 301-312.
21. Rasouly D, Shavit D, Zuniga R, Elejalde RB, Unsworth BR, Yajon A, Lazarovici P & Lelkes PI. Staurosporine induces neurite outgrowth in neuronal hybrids (PC1 2EN) lacking NGF receptors. Journal of Cellular Biochemistry 1996 62 356-371.